1 Bret , P , Bret , MC , Queuille , E. Prescribing patterns of antipsychotics in 13 French psychiatric hospitals [in French] . L'Encephale 2009 ; 35 : 129–38.

2 Koranek , AM , Smith , TL , Mican , LM , Rascati , KL . Impact of the CATIE trial on antipsychotic prescribing patterns at a state psychiatric facility . Schizophr Res 2012 ; 137 : 137–40.

3 Park , SC , Lee , MS , Kang , SG , Lee , SH . Patterns of antipsychotic prescription to patients with schizophrenia in Korea: results from the health insurance review and assessment service – national patient sample . J Korean Med Sci 2014 ; 29 : 719–28.

4 Jauhar , S , Guloksuz , S , Andlauer , O , Lydall , G , Marques , JG , Mendonca , L , et al. Choice of antipsychotic treatment by European psychiatry trainees: are decisions based on evidence? BMC Psychiatry 2012 ; 12 : 27 .

5 Cheng , F , Jones , PB . Drug treatments for schizophrenia: pragmatism in trial design shows lack of progress in drug design . Epidemiol Psychiatr Sci 2013 ; 22 : 223–33.

6 Underwood , BR . Dominance of second-generation antipsychotics – time for reflection? Psychiatr Bull 2007 ; 31 : 233 .

7 Jones , PB , Barnes , TR , Davies , L , Dunn , G , Lloyd , H , Hayhurst , KP , et al. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1) . Arch Gen Psychiatry 2006 ; 63 : 1079–87.

8 Lewis , S , Lieberman , J. CATIE and CUtLASS: can we handle the truth? Br J Psychiatry 2008 ; 192 : 161–3.

9 Lieberman , JA , Stroup , TS , McEvoy , JP , Swartz , MS , Rosenheck , RA , Perkins , DO , et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia . N Engl J Med 2005 ; 353 : 1209–23.

10 Peluso , MJ , Lewis , SW , Barnes , TR , Jones , PB . Extrapyramidal motor side-effects of first- and second-generation antipsychotic drugs . Br J Psychiatry 2012 ; 200 : 387–92.

11 National Institute for Health and Care Excellence . Psychosis and Schizophrenia: Treatment and Management . NICE , 2014 .

12 Farde , L , Nordstrom , AL , Wiesel , FA , Pauli , S , Halldin , C , Sedvall , G. Positron emission tomographic analysis of central D 1 and D 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects . Arch Gen Psychiatry 1992 ; 49 : 538–44.

13 Owens , DC . Meet the relatives: a reintroduction to the clinical pharmacology of ‘typical’ antipsychotics (Part 2) . Adv Psychiatr Treat 2012 ; 18 : 337–50.